INDUSTRIES — PHARMACEUTICAL

Pharmaceutical packing without a capital project.

Secondary packaging and end-of-line handling on lines where changeover discipline and consistency matter more than raw speed.

  • COMMERCIAL SHAPE MONTHLY OPEX
  • QUOTE TO RUNNING SYSTEM 8–12 WEEKS
  • PROOF PATH 90-DAY PILOT
(01) THE PRESSURE vs. THE FIT

WHAT'S BREAKING — ON THE FLOOR

[P—01]

Every line change carries paperwork

Change control makes teams delay automation until the case is overwhelming — so the packing bench keeps absorbing the work.

[P—02]

Batch sizes keep shrinking

Shorter runs and more SKUs push variability straight onto end-of-line, usually in the form of more hands.

[P—03]

Capital goes elsewhere first

Formulation, plant and compliance spend win the capital argument against packing automation every time.

HOW RENTAL FITS — THE ARR ANSWER

[F—01]

No capital case to win

Rental sits in operating spend from the first month, so end-of-line stops competing with R&D and compliance for the same budget.

[F—02]

Scoped around changeover, not just speed

We scope pack format, changeover rhythm and the way your line already runs before the system ships.

[F—03]

Prove it on one line first

The pilot puts a system on a single line so the business sees evidence before anything scales across the site.

YOUR LINE. YOUR NUMBERS. 15 MINUTES.

Talk to someone who's seen your line.